Well, it's well known that I'm a bit of a Pollyanna, but I'm thinking that this isn't really about "backroom deals" or "settling off the books." Maybe someone can help me out, but I just don't see how the FDA can reach a settlement with TW without acknowledging that TW's product is a tobacco product.
The FDA has taken the position that e-cigs are subject to pharma regulations. Period. There has been no wiggle room in the FDA's position. If the FDA intends to maintain that position and not back off, I simply don't see how it can reach any kind of settlement with TW other than perhaps agree that the preliminary injunction that NJOY won (that stops the FDA from seizing NJOY's shipments during pendency of the case) will also apply to TW. In that event, there would still be litigation, but while the litigation is ongoing, TW would have its shipments protected.
But to totally resolve the matter without litigation would require some acknowledgment from the FDA that TW's product is tobacco. And, like I said, once one vendor is "blessed" with a tobacco classification, it provides some safe harbor for other vendors to get the same treatment if their marketing/advertising is similar enough.
And honestly, the FDA really doesn't lose much by regulating e-cigs as tobacco products. The bad eggs out there (those making health claims) will get nasty-grams from the FDA (or worse), telling them that their business practices have placed them in a pharma category (which wouldn't be good at all for those vendors--they'll have to most likely pull their products or adopt different marketing/advertising). As for those vendors who would fall within the tobacco classification, the FDA will be able to regulate the hell out of them.
I guess what I'm saying is that however you look at it, the FDA will be able to flex its regulatory muscle over e-cigs, so it probably makes sense for the FDA to bow to the inevitable and just start trying to figure out how to regulate e-cigs within a tobacco framework.
Then again, I could be all wrong.